Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000063

Chief Operating Officer sold 58,625 shares at an average $20.09 ($1,177,967)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-26 Sale : show line 1 in the form 10b5-1 −24,555 $20.07 $492,819 274,323 D
2024-02-27 Sale : show line 2 in the form 10b5-1 −34,070 $20.11 $685,148 240,253 D
Open-market sales · 58,625 sh · avg $20.09 · $1,177,967
Loading xslF345X05/wk-form4_1709168145.xml…